On Rare Disease Day, we are united in recognizing the 300 million people worldwide living with rare diseases, many of whom may be immunocompromised and vulnerable to serious viral infections like COVID-19.?#rarediseaseday
Invivyd
生物技术研究
Waltham,Massachusetts 12,653 位关注者
Invivyd creates medicines that are more potent and resistant to virus evolution than the human immune system.
关于我们
Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised
- 网站
-
https://www.invivyd.com
Invivyd的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Waltham,Massachusetts
- 类型
- 上市公司
- 创立
- 2020
地点
-
主要
1601 Trapelo Rd
Suite 178
US,Massachusetts,Waltham,02451
Invivyd员工
动态
-
We are excited to be in Scottsdale, AZ to attend the Cutting Edge of Transplantation 2025 Transplant Summit. We look forward to meeting members of the transplant community! #CEoT2025 #OrganDonation #donatelife
-
-
Reminder! In partnership with National Infusion Center Association (NICA), join us TODAY at 12:00 PM Central for an insightful webinar exploring the persistent impact of COVID-19 and the evolving challenges posed by the SARs-CoV-2 virus. Registration is still open: https://lnkd.in/eqTHQZYh Gain a deeper understanding of the virus's ongoing evolution and its implications for healthcare providers, ensuring you stay informed and prepared to support vulnerable patients in your infusion practice.
In collaboration with the National Infusion Center Association (NICA), we’re excited to invite healthcare professionals to a webinar on February 27th at 12:00 p.m. CST exploring the ongoing impact of COVID-19 on certain immunocompromised patients. Attendees will hear expert speakers address the systemic complications that COVID-19 continues to cause, the heightened risk that certain immunocompromised individuals may face, and potential limitations of current vaccine efficacy in the immunocompromised population. To register, please click the link here or scan the QR code. We hope to see you there! https://lnkd.in/eqTHQZYh
-
We are happy to share the latest episode of The Sick Times “Still Here” podcast where Invivyd’s Chairman Marc Elia speaks with co-host Miles Griffis about his recent op-ed in The Sick Times about how bureaucracy is killing people with Long Covid and the role of monoclonal antibodies in the ongoing pandemic. https://lnkd.in/eTETPd5H #demandmoreoptions #covid #covid19 #LongCovid
-
We are thrilled that Coach Jim Harbaugh is continuing to highlight the ongoing damaging impact of COVID-19, and is encouraging Americans to talk to their healthcare providers and visit www.expandtheiroptions.com to learn more. There are options other than vaccines. #covid19 #covid #demandmoreoptions
-
-
We are thrilled to be at the Society of Critical Care Medicine (SCCM) 2025 Critical Care Congress, together with members of the critical care community! Come visit us at booth #738. We hope to see you there! #SCCM2025
-
-
Today we celebrate National Caregivers Day and honor healthcare providers and dedicated family members and friends who work tirelessly and give selflessly to provide care to those in need. Many of these incredible individuals play an essential role in providing support, compassion, strength and advocacy for the millions of Americans whose conditions leave them immunocompromised and vulnerable to serious viral infectious diseases, like COVID-19. Thank you for all that you do! #NationalCaregiversDay #ThankACaregiver
-
-
#DidYouKnow? COVID-19 can cause vascular, systemic, thrombotic disease that damages every organ system. The best way to prevent long-term damage is to protect yourself from COVID-19. Visit www.expandtheiroptions.com for more information. #Covid19 #demandmoreoptions #commonnotacold
-
In collaboration with the National Infusion Center Association (NICA), we’re excited to invite healthcare professionals to a webinar on February 27th at 12:00 p.m. CST exploring the ongoing impact of COVID-19 on certain immunocompromised patients. Attendees will hear expert speakers address the systemic complications that COVID-19 continues to cause, the heightened risk that certain immunocompromised individuals may face, and potential limitations of current vaccine efficacy in the immunocompromised population. To register, please click the link here or scan the QR code. We hope to see you there! https://lnkd.in/eqTHQZYh